heata - SAP Accreditation Stage 5b
heata - SAP Accreditation Stage 5b
批准号:
10104998
负责人:
金额:
$6.36万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2024
资助国家:
英国
项目状态:
未结题
起止时间:
2024 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Almost everything we do today, including you reading this right now, involves a Data Centre (DC). As a result, DCs will consume 10% of TOTAL global electricity by 2030, producing 1.8Gt CO2 p.a., far more than aviation (Shift,2022). Because they generate vast amounts of heat, 40% of their energy is used for cooling, with heat expelled into the atmosphere (Clarke Energy). Capturing this heat represents a significant opportunity for the sector to increase efficiency, reduce costs and generate new revenue streams. Meanwhile, the UK is enduring an acute energy crisis, with average bills increasing by \>100% in 2022\. Urgent solutions are needed to increase home energy efficiency but costs remain prohibitive.Addressing both issues, Bit Warmer (trading as 'heata') has developed a disruptive technology that reimagines the DC as a network of distributed cloud-computing nodes inside people's homes. heata units are fitted onto domestic water cylinders via a thermal contact plate and wired into the immersion spur to heat water (using a British Gas-approved, 'no-plumbing' process). Using broadband, each unit connects into our network, and using proprietary software, BW accesses this network to run cloud services, using the resulting heat to warm the water in the cylinder. By using energy 'twice' (once for processing, once for heating), we deliver a step-change in compute efficiency while reducing energy bills by up to £450 per year per household.heata is on the journey to becoming a SAP-accredited energy efficiency measure, having been working alongside the BRE for the last year. This project would enable us to continue this work to submit our final application next year, in tandem with investigating our requirements under PAS 2030/35\.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
色氨酸代谢-AHR-Th17/Treg轴调控肠屏障功能在SAP继发感染中的作用机制与干预研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:孙思磊
-
依托单位:
肥大细胞通过Chymase介导β细胞高尔基体应激促进SAP后糖尿病发生的机制研究
-
批准号:2025JJ60668
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:崔贝贝
-
依托单位:
Graves病中SLAMF3靶向SAP调控经典NF-κB通路诱导Th17细胞分化的机制研究
-
批准号:2024Y9351
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:姜峥嵘
-
依托单位:
益气通腑法通过 FICZ/AHR/CYP1A1 反馈环调节肠道免疫“截断”治疗 SAP
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:孙贤辉
-
依托单位:
SAP调控RIPK3磷酸化抑制INTAC/RNAPII介导的TIM3转录暂停促进肝细胞肝癌CD8+T细胞耗竭的机制研究
-
批准号:82303892
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:何其峰
-
依托单位:
植原体效应蛋白SAP11通过非泛素化依赖降解途径调控植物发育与抗虫机制解析
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:黄伟杰
-
依托单位:
前边缘皮层疼痛印迹神经元SAP102蛋白参与神经病理痛及其机制研究
-
批准号:32371049
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:万有
-
依托单位:
AC-SAP-MgO协同耦合分时抑缩UHPC物化驱动力及调控机理研究
-
批准号:52368030
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:明阳
-
依托单位:
SAP对CD8+T细胞抗肿瘤免疫应答的调节作用和机制研究
-
批准号:82303172
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:高磊琼
-
依托单位:
RUNX家族通过腺泡细胞-secretion B细胞轴调控SAP炎症免疫微环境的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:费健
-
依托单位: